Nektar Therapeutics
NKTR
#5702
Rank
โ‚น126.01 B
Marketcap
โ‚น3,691
Share price
-0.79%
Change (1 day)
-35.93%
Change (1 year)

Earnings for Nektar Therapeutics (NKTR)

Earnings in 2026 (TTM): -โ‚น14.08 Billion

According to Nektar Therapeutics 's latest financial reports the company's current earnings are โ‚น54.58 Million. In 2025 the company made an earning of -โ‚น14.77 Billion a decrease over its 2024 earnings that were of -โ‚น11.32 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nektar Therapeutics from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น14.08 Billion-4.63%
2025 -โ‚น14.77 Billion30.44%
2024 -โ‚น11.32 Billion-56.85%
2023 -โ‚น26.24 Billion-24.31%
2022 -โ‚น34.66 Billion-30.25%
2021 -โ‚น49.69 Billion17.87%
2020 -โ‚น42.16 Billion0.88%
2019 -โ‚น41.79 Billion-164.46%
2018 โ‚น64.82 B-810.61%
2017 -โ‚น9.13 Billion-37.06%
2016 -โ‚น14.5 Billion89.22%
2015 -โ‚น7.66 Billion48.22%
2014 -โ‚น5.17 Billion-65.93%
2013 -โ‚น15.17 Billion-6.81%
2012 -โ‚น16.28 Billion28.95%
2011 -โ‚น12.63 Billion258.8%
2010 -โ‚น3.52 Billion-63.94%
2009 -โ‚น9.76 Billion-392.45%
2008 โ‚น3.33 B-211.74%
2007 -โ‚น2.99 Billion-79.57%
2006 -โ‚น14.62 Billion-16.9%
2005 -โ‚น17.59 Billion81.53%
2004 -โ‚น9.69 Billion54.19%
2003 -โ‚น6.29 Billion-33.87%
2002 -โ‚น9.51 Billion-9.6%
2001 -โ‚น10.52 Billion73.39%
2000 -โ‚น6.07 Billion108.9%
1999 -โ‚น2.91 Billion39.48%
1998 -โ‚น2.09 Billion60.02%
1997 -โ‚น1.31 Billion18.05%
1996 -โ‚น1.11 Billion31.82%
1995 -โ‚น0.84 Billion57.14%
1994 -โ‚น0.54 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.488 T-17,216.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น655.81 B-4,611.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น976.75 B-6,818.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-โ‚น45.87 Billion 215.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น730.16 B-5,122.40%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.360 T-9,460.35%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
โ‚น0.71 B-104.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
โ‚น22.52 B-254.92%๐Ÿ‡ฎ๐Ÿ‡ช Ireland